- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 15/10 - Drugs for genital or sexual disordersContraceptives for impotence
Patent holdings for IPC class A61P 15/10
Total number of patents in this class: 571
10-year publication summary
|
16
|
11
|
30
|
40
|
40
|
36
|
51
|
31
|
35
|
25
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17679 |
23 |
| Takeda Pharmaceutical Company Limited | 2717 |
8 |
| ASKA Pharmaceutical Co., Ltd. | 104 |
8 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 842 |
8 |
| AstraZeneca AB | 2858 |
7 |
| Pfizer Inc. | 3401 |
7 |
| Kyowa Hakko Bio Co., Ltd. | 294 |
7 |
| ATIR Holding S.A. | 18 |
6 |
| Initiator Pharma A/S | 18 |
6 |
| Topadur Pharma AG | 23 |
6 |
| Banyu Pharmaceutical Co., Ltd. | 53 |
5 |
| Futura Medical Developments Limited | 31 |
5 |
| Topharman Shanghai Co., Ltd. | 53 |
5 |
| Nippon Shinyaku Co., Ltd. | 324 |
4 |
| Shionogi & Co., Ltd. | 835 |
4 |
| Sunshine Lake Pharma Co., Ltd. | 600 |
4 |
| Bristol-myers Squibb Company | 4820 |
3 |
| AstraZeneca UK Limited | 604 |
3 |
| Boehringer Ingelheim International GmbH | 4635 |
3 |
| The Johns Hopkins University | 5751 |
3 |
| Other owners | 446 |